Omeros

Omeros reports 4Q loss
Omeros reports 4Q loss
Yahoo/AP
Omeros
earnings
Flag link:
Omeros suspends OMS824 trial in Huntington's Disease
Omeros suspends OMS824 trial in Huntington's Disease
Seeking Alpha
Omeros
OMS824
Huntington's disease
Flag link:
FDA approves Omeros eye drug
FDA approves Omeros eye drug
Yahoo/Reuters
FDA
Omeros
Omidria
cataracts
Flag link:
2nd Half Of 2014 Biotechnology Catalysts: Part 1
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
AcelRx
Anacor
BioDelivery Sciences
Eagle Pharmaceuticals
MannKind
Navidea Biopharmaceuticals
Orexigen
Omeros
EnteroMedics
Progenics
Trimel Pharmaceuticals
Flag link:
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Medicines Company
Omeros
OPKO Health
Vivus
OMS721
Qsymia
Fibrocaps
Flag link:
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Motley Fool
Dendreon
AbbVie
Omeros
Provenge
prostate cancer
ABT-450
hepatitis C
OMS721
Flag link:
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
Motley Fool
Nektar
Omeros
Spectrum Pharmaceuticals
Flag link:
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Reuters
Omeros
OMS824
cognitive disorders
Flag link:
Positive Data on Omeros' OMS824
Positive Data on Omeros' OMS824
Yahoo/Zacks.com
Omeros
OMS824
schizophrenia
Flag link:
2014 FDA Drug Approval Decision Calendar
2014 FDA Drug Approval Decision Calendar
TheStreet.com
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Flag link:
Omeros' OMS721 shows positive Phase 1 clinical trial results
Omeros' OMS721 shows positive Phase 1 clinical trial results
Yahoo/Fly on the Wall
Omeros
OMS721
Flag link:
Omeros gets approval to study eye surgery drug in children; could extend marketing exclusivity
Omeros gets approval to study eye surgery drug in children; could extend marketing exclusivity
Yahoo/AP
Omeros
eye surgery
OMS302
Flag link:
What's Moving These 3 Biotechs?
What's Moving These 3 Biotechs?
Motley Fool
Ligand
Pfizer
Vivus
Omeros
Flag link:
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Yahoo
FDA
orphan drugs
Omeros
OMS824
Huntington's disease
Flag link:
Some Speculative Biotechs Making Major Moves
Some Speculative Biotechs Making Major Moves
Seeking Alpha
Dynavax
Omeros
Pacific Biosciences
Flag link:
3 Humongous Health-Care Stocks This Week
3 Humongous Health-Care Stocks This Week
Motley Fool
Omeros
Enanta
AbbVie
Flag link:
Omeros' OMS824 shows positive Phase 1 results
Omeros' OMS824 shows positive Phase 1 results
Yahoo
Omeros
OMS824
Huntington's disease
schizophrenia
Flag link:
Income And Excitement Are Things Omeros Offers
Income And Excitement Are Things Omeros Offers
Seeking Alpha
Omeros
Flag link:
Is This Biotech A Value Stock Or Value Trap?
Is This Biotech A Value Stock Or Value Trap?
Seeking Alpha
Omeros
Flag link:
Omeros Corporation's Stock Has Potential To Double This Year
Omeros Corporation's Stock Has Potential To Double This Year
Seeking Alpha
Omeros
OMS302
Flag link:

Pages